The University of Minnesota is seeking candidates at the tenure-track (Assistant Professor) or tenured (Associate or Full Professor) level for appointment as part of a multi-departmental endeavor across the Medical School to work in the field of drug addiction. The overarching vision is to link basic research to new therapeutic approaches in treating substance abuse. The State of Minnesota has appropriated significant funds over the next ten years for the University of Minnesota Medical School to create a world-class, neuroscience-based program for the study and treatment of addiction. Individuals, whose research programs focus on relevant areas of addiction, such as the neurocircuitry, roles of stress and emotional-regulation, neuronal plasticity, mechanisms of drug craving, reward and relapse, abstinence and novel approaches to prevention and treatment, are especially encouraged to apply. Faculty recruited into the Medical Discovery Team will be housed together in advanced laboratory space at the center of the University’s Biomedical Discovery District to foster scientific partnership and teamwork. The full vision is to promote synergy in order to advance discovery, which will also require aggressive targeting of federal funding. Faculty members, both basic scientists and physician-scientists from diverse disciplines, including Neuroscience, Neurology, Pharmacology, Psychiatry, and Radiology are encouraged to apply. Up to four faculty members will be hired in this initial search, with an additional four to six faculty members to be hired in future years.
The Medical Discovery Team will be integrated into the University of Minnesota’s current faculty, who have research strengths in addiction. The National Institute on Drug Abuse (NIDA)-based research funding currently stands at ~$15M per year. Funded research includes studies of psychostimulants, nicotine, and opioids. We serve as the NorthStar Node of the NIDA Clinical Trials Network - a newly established national platform for pragmatic clinical effectiveness trials in addiction. A recently funded program is in the process of developing a vaccine against opioid addiction for clinical trials. In addition, addiction-based research is funded by the National Institute on Alcohol Abuse and Alcoholism (NIAAA), the National Cancer Institute (NCI) and the National Heart, Lung, and Blood Institute (NHLBI) at ~$12M per year. The University of Minnesota has had a strong history of collaborative and transdisciplinary investigation in addiction research.
Additional strengths at the University of Minnesota include: the internationally-recognized Center for Magnetic Resonance Research - at the forefront of the Human Connectome project; the Institute for Therapeutics Discovery and Development with the resources and expertise to develop new drug therapies; and the Clinical and Translational Science Institute, which provides resources to implement new treatment strategies and is a conduit to promote the community-wide understanding and application of scientific discoveries.
Minnesota is the home of multiple biomedical research companies where development of therapeutic approaches to addiction is a priority. Minnesota is also the home of world-renowned hospitals and treatment centers for addiction. Leveraging university relationships with these resources throughout Minnesota will aid the team in achieving their goals.
The University of Minnesota is an equal opportunity educator and employer.